Tianjin Medical University General Hospital

Direct Digital Holdings Appoints Diana Diaz as Chief Financial Officer

Retrieved on: 
Wednesday, October 18, 2023
Jesse H. Jones Graduate School of Business, Risk, Rice University, DRCT, BBA, Financial condition report, Result, Security (finance), Tax, Colossus, Conversation, Tianjin Medical University General Hospital, Memorial Hermann Health System, Treasury, Disclosure, Acquisition, Texas Medical Center, Reliant Energy, Software, Advertising, Controller, SMED, Growth, IDS, Marketing, Analysis, University of Texas at Austin, University, Rice University Electrical and Computer Engineering, Computer, Accounting, Failure, Management

HOUSTON, Oct. 18, 2023 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP"), Huddled Masses LLC ("Huddled Masses") and Orange142, LLC ("Orange142"), today announced that the Company appointed Diana Diaz, who had been serving as the Company's interim Chief Financial Officer, as permanent Chief Financial Officer, effective October 16, 2023.

Key Points: 
  • HOUSTON, Oct. 18, 2023 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP"), Huddled Masses LLC ("Huddled Masses") and Orange142, LLC ("Orange142"), today announced that the Company appointed Diana Diaz, who had been serving as the Company's interim Chief Financial Officer, as permanent Chief Financial Officer, effective October 16, 2023.
  • Ms. Diaz served as interim Chief Financial Officer of Direct Digital Holdings beginning June 5, 2023.
  • As permanent Chief Financial Officer, she will continue to lead the Company's finance, accounting and treasury organization and report directly to the Company's Chief Executive Officer.
  • Mark D. Walker, Chairman and Chief Executive Officer, commented, "We are grateful for the hard work and dedication Diana has provided our team over the past several months and greatly excited to appoint her as our permanent Chief Financial Officer.

Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China

Retrieved on: 
Saturday, January 28, 2023
National Center for Biotechnology Information, BioMed Central, Artificial intelligence, Emergency medicine, Death, Septic shock, Tianjin Medical University General Hospital, Meta-analysis, Medicine, National Center for Telehealth & Technology, ASEP, CSE, Hospital, Map, Patient, Sepsis, Mortality, Research, Pharmaceutical industry

VANCOUVER, BC, Jan. 27, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce that it has signed a joint venture term sheet with a leading Chinese medical diagnostic company, Sansure Biotech Inc. (Sansure).

Key Points: 
  • VANCOUVER, BC, Jan. 27, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce that it has signed a joint venture term sheet with a leading Chinese medical diagnostic company, Sansure Biotech Inc. (Sansure).
  • The term sheet was signed on September 29, 2022.
  • Both parties will continue to negotiate the specific collaboration terms toward the goal of entering into a definitive agreement in the coming months.
  • The term sheet is a road map for a joint venture in preparation for the research, development, use, sublicensing and commercialization of SepsetER, Asep Inc.'s first-generation sepsis diagnostic kit for use in the Chinese market.

FONDAZIONE PRADA PRESENTS "HUMAN BRAINS: PRESERVING THE BRAIN - FORUM ON NEURODEGENERATIVE DISEASES"

Retrieved on: 
Tuesday, September 6, 2022
Harvard Medical School, Lists of diseases, Max Planck Institute of Neurobiology, Helmholtz Association, University, University College London, Consciousness, Fondazione Prada, Research, Exhibition, Multiple sclerosis, Tianjin Medical University General Hospital, DZNE, Amyotrophic lateral sclerosis, Cone Health Women's Hospital, Lebanese Army Teaching Institute, German Center for Neurodegenerative Diseases, Yale School of Medicine, Weizmann Institute of Science, Organization, Alzheimer's disease, Neurodegeneration, Hospital, Neurology, History, Knowledge, Association, Human, Medical device, Pharmaceutical industry, Medicine, Brain, Brigham, Neuroscience

The fourth phase of "Human Brains, titled "Preserving the Brain Forum on Neurodegenerative Diseases", will comprise an exhibition (16 September 10 October 2022) and a conference (6 and 7 October 2022) at Fondazione Prada's Milan premises.

Key Points: 
  • The fourth phase of "Human Brains, titled "Preserving the Brain Forum on Neurodegenerative Diseases", will comprise an exhibition (16 September 10 October 2022) and a conference (6 and 7 October 2022) at Fondazione Prada's Milan premises.
  • "Preserving the Brain" aims to stimulate an open and critical exchange between internationalscientists and experts on neurodegenerative diseases, such as Alzheimer's, Parkinson's,Amyotrophic lateral sclerosis and Multiple sclerosis, which are widely spread and as yetincurable.
  • 'Preserving the Brain' also demonstrates how critical collaboration and sharing of knowledge are within the scientific community.
  • The pivotal moment of "Preserving the Brain" will be the scientific conference held on 6 and 7 October 2022, at Fondazione Prada's Cinema in Milan.

FONDAZIONE PRADA PRESENTS "HUMAN BRAINS: PRESERVING THE BRAIN - FORUM ON NEURODEGENERATIVE DISEASES"

Retrieved on: 
Tuesday, September 6, 2022
Harvard Medical School, Lists of diseases, Max Planck Institute of Neurobiology, Helmholtz Association, University, University College London, Consciousness, Fondazione Prada, Research, Exhibition, Multiple sclerosis, Tianjin Medical University General Hospital, DZNE, Amyotrophic lateral sclerosis, Cone Health Women's Hospital, Lebanese Army Teaching Institute, German Center for Neurodegenerative Diseases, Yale School of Medicine, Weizmann Institute of Science, Organization, Alzheimer's disease, Neurodegeneration, Hospital, Neurology, History, Knowledge, Association, Human, Medical device, Pharmaceutical industry, Medicine, Brain, Brigham, Neuroscience

The fourth phase of "Human Brains, titled "Preserving the Brain Forum on Neurodegenerative Diseases", will comprise an exhibition (16 September 10 October 2022) and a conference (6 and 7 October 2022) at Fondazione Prada's Milan premises.

Key Points: 
  • The fourth phase of "Human Brains, titled "Preserving the Brain Forum on Neurodegenerative Diseases", will comprise an exhibition (16 September 10 October 2022) and a conference (6 and 7 October 2022) at Fondazione Prada's Milan premises.
  • "Preserving the Brain" aims to stimulate an open and critical exchange between internationalscientists and experts on neurodegenerative diseases, such as Alzheimer's, Parkinson's,Amyotrophic lateral sclerosis and Multiple sclerosis, which are widely spread and as yetincurable.
  • 'Preserving the Brain' also demonstrates how critical collaboration and sharing of knowledge are within the scientific community.
  • The pivotal moment of "Preserving the Brain" will be the scientific conference held on 6 and 7 October 2022, at Fondazione Prada's Cinema in Milan.